GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $7,000 | -22.2% | 18,750 | 0.0% | 0.00% | – |
Q2 2016 | $9,000 | -95.4% | 18,750 | -85.4% | 0.00% | -100.0% |
Q4 2014 | $194,000 | -26.0% | 128,400 | +1.0% | 0.00% | 0.0% |
Q3 2014 | $262,000 | -39.2% | 127,100 | -9.6% | 0.00% | -50.0% |
Q2 2014 | $431,000 | +683.6% | 140,625 | +542.1% | 0.00% | – |
Q1 2014 | $55,000 | +150.0% | 21,900 | +119.0% | 0.00% | – |
Q2 2013 | $22,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EQUITEC SPECIALISTS, LLC | 314,900 | $147,000 | 0.03% |
EQUITEC SPECIALISTS, LLC | 120,300 | $56,000 | 0.01% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 39,000 | $18,000 | 0.01% |
Alyeska Investment Group, L.P. | 1,593,277 | $743,000 | 0.01% |
Aspen Investment Management Inc | 15,000 | $7,000 | 0.01% |
GROUP ONE TRADING, L.P. | 966,068 | $450,000 | 0.01% |
Acrospire Investment Management LLC | 11,300 | $5,000 | 0.00% |
SABBY MANAGEMENT, LLC | 113,530 | $53,000 | 0.00% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $5,000 | 0.00% |
ACG Wealth | 25,000 | $12,000 | 0.00% |